✦ LIBER ✦

Gene therapy with HSV-TK of pancreatic cancer cell lines: Different responses to GCV treatment

✍ Scribed by Greco, Eliana; Fogar, Paola; Basso, Daniela; Parolin, Cristina; Stefani, Annalisa; Pasquali, Claudio; Plebani, Mario; Pedrazzoli, Sergio

Book ID: 123603529
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 202 KB
Volume: 118
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(00)86312-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cancer gene therapy with HSV-tk/GCV syst

Cancer gene therapy with HSV-tk/GCV system depends on t-cell-mediated immune responses and causes apoptotic death of tumor cells In vivo

✍ Shigeki Kuriyama; Masaji Kikukawa; Kazuhiro Masui; Hirotsugu Okuda; Toshiya Naka 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 620 KB

To examine the immunological mechanisms involved in cancer gene therapy using the herpes simplex virus thymidine kinase (HSV-tk) gene and ganciclovir (GCV), murine hepatocellular carcinoma (HCC) cells, BNL1ME A.7R.1, were transduced retrovirally with the HSV-tk gene. HSV-tk-transduced cells exhibite

Identification of novel genes associated

Identification of novel genes associated with the response to 5-FU treatment in gastric cancer cell lines using a cDNA microarray

✍ Ji-Seon Park; Sun Young Yoon; Jeong-Min Kim; Young-Il Yeom; Yong Sung Kim; Nam-S 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 615 KB

Marimastat may not improve survival over

Marimastat may not improve survival over placebo following induction therapy for small-cell lung cancer: Abstracted from: Shepherd F, Giaccone G, Seymour L et al. Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer. J Clin Oncol 2002; 20(22): 4434–39.

✍ B Coudert 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 71 KB